Rajkot (Gujarat), Tuesday, June 19, 2018: Rajkot based Anlon Healthcare Private Limited, is going to participate in the forthcoming CPhI China scheduled from June 20- 22, 2018 at the Shanghai New International Expo Center. CPhI China is one of the leading Global Exhibitions in which all major bulk drug, Intermediates and Pharmaceutical manufacturers participate.
Mr. Punit Rasadia, Managing Director of Anlon who has already reached on the land of the dragon, said that CPhI China is a great way to tap into the market and connect with the potential business houses from all across the globe. Apart from networking with existing business associates, CPhI provides an excellent opportunity to learn new things about the fast changing pharma and allied industries.
The event represents a great opportunity to connect with China’s market leaders, meet existing clients, stay on top of industry trends and regulations. Organizers of the expo are expecting huge growth in international attendees this year because of the changed regulations and scenario with all manufacturing units.
According to the 2017 CPhI Global Pharma Index, China remains a region with unmatched growth potential and projects total pharmaceutical sales to be $158 billion in 2018. With the recent regulatory reforms by the China Food and Drug Administration (China FDA), efforts are being made to harmonize China’s regulations to match with international regulations.
CPhI report says that China has the most pharma manufacturers in the world, with 6500 companies producing 1500 APIs. Due to rapid growth of generic-drug production in China for domestic and exports consumption, CPhI China earmarked a specific zone – PharmaExcipients – decided to the pharma and chemical industries.
To know more about Anlon Healthcare Private Limited, please log on to: www.anlon.in